Definitive Contract HHSN275201200011C

This firm fixed-price purchase order, valued at $10,900, was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Pointcare Systems Inc. R&D Division, doing business as Chirosolve, for the synthesis of tert-butyl (R)-3-(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)piperidine-1-carboxylate in a 75 gram quantity with over 95% purity. The solicitation sought synthesis and delivery of the specified intermediate...

The National Cancer Institute awarded a $3.17M cost-plus-fixed-fee delivery order to Alchem Laboratories Corporation for the synthesis of up to ten non-Good Manufacturing Practice (GMP) small molecule sample compounds per year, with an ultimate completion date of September 19, 2026. This award, designated as a Total Small Business set-aside, supports continuity for the Institute's Program 66C and leverages Alchem's specialized capabilities in custom organic synthesis and analytical services...

The National Institute on Drug Abuse awarded a $101,000 firm fixed-price purchase order to Chemogenics Biopharma, LLC on September 16, 2025, for synthesis and bioanalytical analysis services supporting the National Center for Advancing Translational Sciences (NCATS) Early Translational Branch Chemistry Program. The contract, which extends through July 15, 2026, is performable in Durham, North Carolina. This procurement does not utilize a small business set-aside designation. The work involves...

This firm fixed-price contract for $80,300 was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Affinity Research Chemicals Inc. of Stanton, Delaware. The contract calls for the delivery of 5 kilograms of non-GMP grade methyl 4-(((5-phenylpyrazin-2-yl)methyl)carbamoyl)benzoate, a key intermediate and regulatory starting material required for further process development and cGMP manufacture of the...

This is a $2,332,902 cost-plus-fixed-fee delivery order awarded by the National Cancer Institute (NCI) to Alchem Laboratories Corporation, a for-profit manufacturer based in Florida. The contract is for the synthesis of non-GMP (non-Good Manufacturing Practice) small molecule samples to support the NCI's research. Alchem Laboratories has multiple federal indefinite delivery vehicle (IDV) contracts with the NCI and National Institute of Allergy and Infectious Diseases (NIAID) for preclinical...

The U.S. Food and Drug Administration (FDA) awarded a firm fixed-price purchase order valued at $145,275 to Mettler-Toledo Autochem, Inc. to procure an automated laboratory reactor. The contract is being performed in Columbia, Maryland from July 2023 through July 2024 to fulfill requirements outlined in FDA solicitation number CDER-2023-118133. This solicitation requested an automated laboratory reactor to support work at the FDA's Center for Drug Evaluation and Research. Mettler-Toledo...

This is a definitive federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Alchem Laboratories Corporation, a for-profit manufacturer of pharmaceutical ingredients. The $2,860,070.26 cost-plus-fixed-fee contract is for the manufacture of bulk chemicals and pharmaceutical ingredients to support preclinical and clinical studies. The contract has a completion date of June 4, 2022 and was set aside for small businesses. Alchem Laboratories is the prime contractor and...

The National Institute of Environmental Health Sciences awarded a $5,434 purchase order to Moravek Biochemicals, Inc. for the synthesis of tritium-labeled compounds. The contract, awarded on July 1, 2009, with an ultimate completion date of September 30, 2010, represents a standard commercial acquisition with no small business set-aside designation. The work will be performed at Moravek Biochemicals' facility in Brea, California, under the direction of requestor Bernice Samuels at Building 50,...

Cayman Chemical Co Inc., a specialized biochemical manufacturer based in Ann Arbor, Michigan, has been awarded a $230,365 firm fixed-price purchase order by the Drug Enforcement Administration (DEA) for the synthesis of drug substances. The contract, awarded on January 22, 2026, with an ultimate completion date of August 31, 2026, follows the company's response to a DEA Aviation Division Sources Sought notice issued in late December 2025. The opportunity sought vendors capable of providing...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $1,725,000.00 definitive, firm-fixed-price contract to Polypeptide Laboratories San Diego, LLC (doing business as Polypeptide Labs) to provide 3.5 kilograms of current Good Manufacturing Practice (GMP) synthetic Preimplantation Factor (sPIF) peptide. The contract, which does not have a set-aside designation, was awarded on August 14, 2018 with a completion date...